Short-term efficacy and safety of neoadjuvant pyrotinib plus taxanes for early HER2-positive breast cancer: a single-arm exploratory phase II trial

Guolin Ye, Peixian Chen, Xiangwei Liu, Tiancheng He, Xavier Pivot, Ruilin Pan, Dan Zhou, Lewei Zhu, Kun Zhang, Wei Li, Shuqing Yang, Jiawei Lin, Gengxi Cai, Huiqi Huang